B3QM08 AF NFT

Leucine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeidaogm6eo5ujhwsuddr72sh3gne4gt2kjnuc6mh35gamc4ldqlpia/metadata.json
IPFS of structure file: 
bafybeidr3bb3toiqyufewtisekwg3qwwyrtvwzjvtpu3ysg5zhe2ydka2m/AF-B3QM08-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x7FDF8b382C6a36A8772D1A265E8e480c7DF0A9C1
First NFT owner address (bech32): 
genesis10l0ckwpvdgm2saedrgn9arjgp37lp2wpyzq5qn
Current NFT ID #449950 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
449950
Accession (UniProt):
B3QM08
Name::
Leucine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
Chlorobaculum parvum (strain DSM 263 / NCIMB 8327)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B3QM08 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B3QM08|SYL_CHLP8 Leucine--tRNA ligase OS=Chlorobaculum parvum (strain DSM 263 / NCIMB 8327) OX=517417 GN=leuS PE=3 SV=1 MKYDFSALEKKWQARWADEQTFASSADQDKPKYYVLDMFPYPSGSGLHVGHLEGYTATDIMARYKRCQGHNVLHPMGWDAFGLPAEQFAIKTGTHPRLTTEKNVASFRETLKSMGFSYDWSREVNTTDPNYFKWTQWIFLKLYEKGLAYISEVDVNWCEELKVVLANEEVDEKIADGYTVVRRPLRQWVLKITAYAERLLEDLDEVDWPENVKQMQRNWIGRSEGVEIDFELRCHRTNLRVYTTRPDTLFGATYLVISPEHPMAEKLAIAQQLVEVKKYIEQAKLKTELERTGLQKEKTGVFTGSYAINPANGEALPVWISDFVLTSYGTGAIMSVPAHDSRDWEFAKKFGLPIREVIKSPHDVQEEVFDGKESVCVNSANDEISIDGLDFKTAFDRMATWLESKGKGKRKVNYKLRDWVFSRQRYWGEPIPIKHYEDGTMRPETNLPLTLPEVEAYHPTSTGESPLANIESWLYGEDEHGKFRRETNTMPQWAGSCWYYLRFIDPQNGNALVDPSREQYWMNVDLYIGGAEHAVLHLLYSRFWHKVLYDLGVVSTKEPFQRLFNQGMILGEDNEKMSKSRGNVIPADHVLSTYGADAVRLYEMFLGPLEQVKPWNTHGIEGISRFLNKVWRLVWDENTETQKTTDDKPSEAVLKRMHKAIKKVTEDTEQLKFNTAISEMMVLVNELTKTGCYSRETTETLLVLLSPFAPHITEELWQTLGHTESISGAVWPVFDAKLATDDVLTIAVQVNGKLRGTFEAPAGYAKEDMIESAKKVESVAKFLEGQQIIKEIAVPGKLVNFAVKPQQ